These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
425 related articles for article (PubMed ID: 25336438)
1. Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes in oropharyngeal cancer stratified by human papillomavirus status. Huang SH; Waldron JN; Milosevic M; Shen X; Ringash J; Su J; Tong L; Perez-Ordonez B; Weinreb I; Bayley AJ; Kim J; Hope A; Cho BC; Giuliani M; Razak A; Goldstein D; Shi W; Liu FF; Xu W; O'Sullivan B Cancer; 2015 Feb; 121(4):545-55. PubMed ID: 25336438 [TBL] [Abstract][Full Text] [Related]
2. Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis. O'Sullivan B; Huang SH; Siu LL; Waldron J; Zhao H; Perez-Ordonez B; Weinreb I; Kim J; Ringash J; Bayley A; Dawson LA; Hope A; Cho J; Irish J; Gilbert R; Gullane P; Hui A; Liu FF; Chen E; Xu W J Clin Oncol; 2013 Feb; 31(5):543-50. PubMed ID: 23295795 [TBL] [Abstract][Full Text] [Related]
3. Atypical clinical behavior of p16-confirmed HPV-related oropharyngeal squamous cell carcinoma treated with radical radiotherapy. Huang SH; Perez-Ordonez B; Liu FF; Waldron J; Ringash J; Irish J; Cummings B; Siu LL; Kim J; Weinreb I; Hope A; Gullane P; Brown D; Shi W; O'Sullivan B Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):276-83. PubMed ID: 20950953 [TBL] [Abstract][Full Text] [Related]
5. Impact of cisplatin dose intensity on human papillomavirus-related and -unrelated locally advanced head and neck squamous cell carcinoma. Spreafico A; Huang SH; Xu W; Granata R; Liu CS; Waldron JN; Chen E; Ringash J; Bayley A; Chan KK; Hope AJ; Cho J; Razak AA; Hansen A; Jang R; Perez-Ordonez B; Weinreb I; Bossi P; Orlandi E; Licitra LF; Song Y; O'Sullivan B; Siu LL; Kim J Eur J Cancer; 2016 Nov; 67():174-182. PubMed ID: 27669504 [TBL] [Abstract][Full Text] [Related]
6. Detailed Analysis of Clinicopathologic Factors Demonstrate Distinct Difference in Outcome and Prognostic Factors Between Surgically Treated HPV-Positive and Negative Oropharyngeal Cancer. Iyer NG; Dogan S; Palmer F; Rahmati R; Nixon IJ; Lee N; Patel SG; Shah JP; Ganly I Ann Surg Oncol; 2015 Dec; 22(13):4411-21. PubMed ID: 25801358 [TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus frequency in oral and oropharyngeal cancer in Greece. Romanitan M; Näsman A; Ramqvist T; Dahlstrand H; Polykretis L; Vogiatzis P; Vamvakas P; Tasopoulos G; Valavanis C; Arapantoni-Dadioti P; Banis K; Dalianis T Anticancer Res; 2008; 28(4B):2077-80. PubMed ID: 18751378 [TBL] [Abstract][Full Text] [Related]
8. Refining American Joint Committee on Cancer/Union for International Cancer Control TNM stage and prognostic groups for human papillomavirus-related oropharyngeal carcinomas. Huang SH; Xu W; Waldron J; Siu L; Shen X; Tong L; Ringash J; Bayley A; Kim J; Hope A; Cho J; Giuliani M; Hansen A; Irish J; Gilbert R; Gullane P; Perez-Ordonez B; Weinreb I; Liu FF; O'Sullivan B J Clin Oncol; 2015 Mar; 33(8):836-45. PubMed ID: 25667292 [TBL] [Abstract][Full Text] [Related]
9. Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis. Weinberger PM; Yu Z; Haffty BG; Kowalski D; Harigopal M; Brandsma J; Sasaki C; Joe J; Camp RL; Rimm DL; Psyrri A J Clin Oncol; 2006 Feb; 24(5):736-47. PubMed ID: 16401683 [TBL] [Abstract][Full Text] [Related]
10. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. Licitra L; Perrone F; Bossi P; Suardi S; Mariani L; Artusi R; Oggionni M; Rossini C; Cantù G; Squadrelli M; Quattrone P; Locati LD; Bergamini C; Olmi P; Pierotti MA; Pilotti S J Clin Oncol; 2006 Dec; 24(36):5630-6. PubMed ID: 17179101 [TBL] [Abstract][Full Text] [Related]
11. The changing incidence of human papillomavirus-associated oropharyngeal cancer using multiple imputation from 2000 to 2010 at a Comprehensive Cancer Centre. Habbous S; Chu KP; Qiu X; La Delfa A; Harland LT; Fadhel E; Hui A; Perez-Ordonez B; Weinreb I; Liu FF; Waldron J; O'Sullivan B; Goldstein D; Xu W; Huang SH; Liu G Cancer Epidemiol; 2013 Dec; 37(6):820-9. PubMed ID: 24184275 [TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus prevalence and prognostic implication in oropharyngeal squamous cell carcinomas. Melkane AE; Auperin A; Saulnier P; Lacroix L; Vielh P; Casiraghi O; Msakni I; Drusch F; Temam S Head Neck; 2014 Feb; 36(2):257-65. PubMed ID: 23728782 [TBL] [Abstract][Full Text] [Related]
13. Pre-treatment absolute lymphocyte count predicts for improved survival in human papillomavirus (HPV)-driven oropharyngeal squamous cell carcinoma. Kreinbrink PJ; Li J; Parajuli S; Wise-Draper TM; Choi DL; Tang AL; Takiar V Oral Oncol; 2021 May; 116():105245. PubMed ID: 33901866 [TBL] [Abstract][Full Text] [Related]
14. Prognostic Implication of Persistent Human Papillomavirus Type 16 DNA Detection in Oral Rinses for Human Papillomavirus-Related Oropharyngeal Carcinoma. Rettig EM; Wentz A; Posner MR; Gross ND; Haddad RI; Gillison ML; Fakhry C; Quon H; Sikora AG; Stott WJ; Lorch JH; Gourin CG; Guo Y; Xiao W; Miles BA; Richmon JD; Andersen PE; Misiukiewicz KJ; Chung CH; Gerber JE; Rajan SD; D'Souza G JAMA Oncol; 2015 Oct; 1(7):907-15. PubMed ID: 26226294 [TBL] [Abstract][Full Text] [Related]
15. Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Patients with Human Papillomavirus-Positive Oropharyngeal Cancer. So YK; Lee G; Oh D; Byeon S; Park W; Chung MK Otolaryngol Head Neck Surg; 2018 Aug; 159(2):303-309. PubMed ID: 29557259 [TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus-driven oropharyngeal cancer and are associated with recurrence. Lang Kuhs KA; Kreimer AR; Trivedi S; Holzinger D; Pawlita M; Pfeiffer RM; Gibson SP; Schmitt NC; Hildesheim A; Waterboer T; Ferris RL Cancer; 2017 Nov; 123(22):4382-4390. PubMed ID: 28950407 [TBL] [Abstract][Full Text] [Related]
17. HLA-A*02 in relation to outcome in human papillomavirus positive tonsillar and base of tongue cancer. Tertipis N; Villabona L; Nordfors C; Näsman A; Ramqvist T; Vlastos A; Masucci G; Dalianis T Anticancer Res; 2014 May; 34(5):2369-75. PubMed ID: 24778045 [TBL] [Abstract][Full Text] [Related]
18. Incidence of human papillomavirus-related oropharyngeal cancer and outcomes after chemoradiation in a population of heavy smokers. Cerezo L; López C; de la Torre A; Suárez D; Hervás A; Ruiz A; Ballestín C; Martín M; Sandoval P Head Neck; 2014 Jun; 36(6):782-6. PubMed ID: 23616290 [TBL] [Abstract][Full Text] [Related]
19. Pretreatment Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker for the Outcome of HPV-Positive and HPV-Negative Oropharyngeal Squamous Cell Carcinoma. Justesen MM; Jakobsen KK; Bendtsen SK; Garset-Zamani M; Mordhorst C; Carlander AF; Gothelf AB; Grønhøj C; von Buchwald C Viruses; 2023 Jan; 15(1):. PubMed ID: 36680237 [TBL] [Abstract][Full Text] [Related]
20. Exploring the Impact of Human Papillomavirus Status, Comorbidity, Polypharmacy, and Treatment Intensity on Outcome of Elderly Oropharyngeal Cancer Patients Treated With Radiation Therapy With or Without Chemotherapy. Caparrotti F; O'Sullivan B; Bratman SV; Ringash J; Lu L; Bayley A; Cho J; Giuliani M; Hope A; Kim J; Waldron J; Hansen A; Goldstein D; Perez-Ordonez B; Weinreb I; Tong L; Song Y; Xu W; Huang SH Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):858-867. PubMed ID: 28258893 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]